Consolidated Balance Sheet
Show table
€ million | Note | Dec. 31, 2014 | Dec. 31, 2013 |
---|---|---|---|
Current assets | |||
Cash and cash equivalents | → 35 | 2,878.5 | 980.8 |
Current financial assets | → 36 | 2,199.4 | 2,410.5 |
Trade accounts receivable | → 37 | 2,235.6 | 2,021.4 |
Inventories | → 38 | 1,659.7 | 1,474.2 |
Other current assets | → 39 | 1,210.2 | 360.7 |
Income tax receivables | → 40 | 297.0 | 109.8 |
Assets held for sale | → 4 | – | 27.1 |
10,480.4 | 7,384.5 | ||
Non-current assets | |||
Intangible assets | → 41 | 11,395.5 | 9,867.2 |
Property, plant and equipment | → 42 | 2,990.4 | 2,647.2 |
Non-current financial assets | → 43 | 94.4 | 77.8 |
Other non-current assets | → 39 | 56.5 | 105.5 |
Deferred tax assets | → 32 | 992.9 | 736.4 |
15,529.7 | 13,434.1 | ||
Total assets | 26,010.1 | 20,818.6 | |
Current liabilities | |||
Current financial liabilities | → 44 | 2,075.9 | 440.4 |
Trade accounts payable | → 45 | 1,539.4 | 1,364.1 |
Other current liabilities | → 46 | 1,574.6 | 1,134.5 |
Income tax liabilities | → 47 | 849.8 | 465.1 |
Current provisions | → 48 | 561.7 | 494.7 |
Liabilities directly related to assets held for sale | – | – | |
6,601.4 | 3,898.8 | ||
Non-current liabilities | |||
Non-current financial liabilities | → 44 | 3,561.1 | 3,257.5 |
Other non-current liabilities | → 46 | 782.0 | 5.6 |
Non-current provisions | → 48 | 626.1 | 1,011.1 |
Provisions for pensions and other post-employment benefits | → 49 | 1,820.1 | 910.9 |
Deferred tax liabilities | → 32 | 818.4 | 665.5 |
7,607.7 | 5,850.6 | ||
Equity | → 50 | ||
Equity capital | 565.2 | 565.2 | |
Reserves | 9,038.9 | 9,341.1 | |
Gains/losses recognized immediately in equity | 2,137.5 | 1,113.7 | |
Equity attributable to Merck KGaA shareholders | 11,741.6 | 11,020.0 | |
Non-controlling interests | 59.4 | 49.2 | |
11,801.0 | 11,069.2 | ||
Total liabilities and equity | 26,010.1 | 20,818.6 |